Sivik Global Healthcare’s BioNTech BNTX Stock Holding History

Sivik Global Healthcare’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,000	Closed	-$1.71M	–	37
2024 Q4	$1.71M	Buy	+15,000	New	+$1.71M	0.9%	33
2024 Q2	–	Sell	-25,000	Closed	-$2.31M	–	41
2024 Q1	$2.31M	Buy	+25,000	New	+$2.4M	0.54%	45
2023 Q1	–	Sell	-13,000	Closed	-$1.95M	–	41
2022 Q4	$1.95M	Buy	+13,000	New	+$2M	0.92%	38
2022 Q2	–	Sell	-10,000	Closed	-$1.71M	–	41
2022 Q1	$1.71M	Buy	+10,000	New	+$1.68M	0.7%	49
2021 Q2	–	Sell	-20,000	Closed	-$2.18M	–	52
2021 Q1	$2.18M	Buy	+20,000	New	+$2.12M	0.8%	40
2020 Q3	–	Sell	-40,000	Closed	-$2.67M	–	46
2020 Q2	$2.67M	Buy	+40,000	New	+$2M	0.88%	43

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Sivik Global Healthcare's BNTX Position: Q1 2025 in Review

Sivik Global Healthcare sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 15,000 shares — an estimated $1.71M sold.

Sivik Global Healthcare first reported a position in BNTX in Q2 2020 and held it in 6 quarters. The position peaked at $2.67M in Q2 2020. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

Sivik Global Healthcare reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
Sivik Global Healthcare sold 15,000 BioNTech shares in Q1 2025, an estimated $1.71M.
Sivik Global Healthcare first reported a position in BioNTech in Q2 2020 and held it in 6 quarters.
Sivik Global Healthcare's BioNTech position peaked at $2.67M in Q2 2020.
280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Sivik Global Healthcare's 13F filing for Q1 2025, filed 22 Apr 2025.